These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21755295)
1. Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells. Dahl M; Bouchelouche P; Kramer-Marek G; Capala J; Nordling J; Bouchelouche K Mol Biol Rep; 2011 Oct; 38(7):4237-43. PubMed ID: 21755295 [TBL] [Abstract][Full Text] [Related]
2. Androgen-dependent regulation of Her-2/neu in prostate cancer cells. Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710 [TBL] [Abstract][Full Text] [Related]
3. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor. Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566 [TBL] [Abstract][Full Text] [Related]
4. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Yeh S; Lin HK; Kang HY; Thin TH; Lin MF; Chang C Proc Natl Acad Sci U S A; 1999 May; 96(10):5458-63. PubMed ID: 10318905 [TBL] [Abstract][Full Text] [Related]
5. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760 [TBL] [Abstract][Full Text] [Related]
6. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations. Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related]
8. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Hsu FN; Yang MS; Lin E; Tseng CF; Lin H Am J Physiol Endocrinol Metab; 2011 May; 300(5):E902-8. PubMed ID: 21364123 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms. Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929 [TBL] [Abstract][Full Text] [Related]
10. Her-2-neu expression and progression toward androgen independence in human prostate cancer. Signoretti S; Montironi R; Manola J; Altimari A; Tam C; Bubley G; Balk S; Thomas G; Kaplan I; Hlatky L; Hahnfeldt P; Kantoff P; Loda M J Natl Cancer Inst; 2000 Dec; 92(23):1918-25. PubMed ID: 11106683 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570 [TBL] [Abstract][Full Text] [Related]
12. Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation. Marrocco DL; Tilley WD; Bianco-Miotto T; Evdokiou A; Scher HI; Rifkind RA; Marks PA; Richon VM; Butler LM Mol Cancer Ther; 2007 Jan; 6(1):51-60. PubMed ID: 17218635 [TBL] [Abstract][Full Text] [Related]
13. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321 [TBL] [Abstract][Full Text] [Related]
14. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related]
16. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
17. GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state. Nadendla SK; Hazan A; Ward M; Harper LJ; Moutasim K; Bianchi LS; Naase M; Ghali L; Thomas GJ; Prowse DM; Philpott MP; Neill GW PLoS One; 2011; 6(5):e20271. PubMed ID: 21633508 [TBL] [Abstract][Full Text] [Related]
18. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304 [TBL] [Abstract][Full Text] [Related]
19. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines. Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965 [TBL] [Abstract][Full Text] [Related]
20. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]